# Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

> **NCT00255138** · PHASE3 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Cancer
- Cognitive Late Effects

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00255138
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255138, "Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00255138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*